Armon Sharei - 30 Jun 2022 Form 4 Insider Report for SQZ Biotechnologies Co

Role
President and CEO, Director
Signature
/s/ Lawrence Knopf, Attorney-in-Fact for Armon Sharei
Issuer symbol
N/A
Transactions as of
30 Jun 2022
Net transactions value
+$6,585
Form type
4
Filing time
05 Jul 2022, 17:00:53 UTC
Previous filing
15 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SQZB Common Stock Award $6,585 +2,436 +0.85% $2.70* 287,884 30 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person is voluntarily reporting the acquisition on June 30, 2022 of 2,436 shares of the issuer's common stock pursuant to the issuer's employee stock purchase plan.